Protect Your Patient Rights Under Healthcare Reform Learn More

We fight to improve the lives of all people affected by celiac disease and non-celiac wheat sensitivity now

Celiac Disease Foundation Attends Genetic Alliance Conference and 30th Anniversary Celebration

Celiac disease is a serious, genetic, autoimmune disorder, and many celiac disease patients have debilitating comorbidities, including cancer, depression and anxiety, and type 1 diabetes, among others. We have long understood that celiac disease patients share common interests with patients of other genetic diseases. These interests include the need for more patient-centered research, realigning government-funded […]

Celiac Disease Foundation Attends Digestive Disease National Coalition Public Policy Forum

As part of Celiac Disease Foundation’s expanding effort to give voice to the celiac disease community in important areas of healthcare policy and federal funding for disease research, on March 5 and 6, 2017, Talia Machlouf, CDF’s Director of Advocacy and Research, attended the Digestive Disease National Coalition Public Policy Forum held in Washington, D.C. The forum gathered […]

Celiac Disease Foundation Launches Celiac Disease Internal Medicine Residency Training Program at USC Keck School of Medicine

Celiac Disease Foundation, in partnership with the University of Southern California (USC) Keck School of Medicine, and CDF Board member Dr. Michael S. Karp, Chief of the Division of Geriatric, Hospital, Palliative and General Internal Medicine, is proud to launch a pioneering celiac disease training program for Internal Medicine residents. This program is made possible […]

Celiac Disease Foundation Partners with ImmusanT to Promote Phase 2 Clinical Trial of Nexvax2®, A Promising Celiac Disease Treatment

ImmusanT, a Cambridge, MA-based biotechnology company, has announced that Nexvax2®, an immunotherapy drug designed to protect celiac disease patients from gluten exposure, has successfully completed a Phase 1b clinical trial and is advancing to a Phase 2 trial. Currently, strict, lifetime adherence to a gluten-free diet is the only disease management protocol for celiac disease […]

Proud Sponsors of Celiac Disease Foundation